Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation
- PMID: 30127174
- PMCID: PMC6113805
- DOI: 10.4103/ijo.IJO_446_18
Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation
Conflict of interest statement
There are no conflicts of interest
Comment on
-
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20. Ophthalmology. 2011. PMID: 21764136 Clinical Trial.
References
-
- Kapoor KG, Wagner MG, Wagner AL. The sustained-release dexamethasone implant: Expanding indications in vitreoretinal disease. Semin Ophthalmol. 2015;30:475–81. - PubMed
-
- Haller JA, Bandello F, Belfort R, Jr, Blumenkranz MS, Gillies M, Heier J, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118:2453–60. - PubMed
-
- Vannozzi L, Bacherini D, Sodi A, Beccastrini E, Emmi G, Giorni A, et al. Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion. Acta Ophthalmol. 2016;94:158–60. - PubMed
-
- Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med. 1997;337:83–90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
